News
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...
Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...
GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...
2d
Zacks Investment Research on MSNGSK's Pentavalent Meningococcal Jab Recommended for Use by ACIPGSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...
2d
Pharmaceutical Technology on MSNACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...
Pharmalittle: We’re reading about Trump team moving on pharma tariffs, PBMs under pressure, and more
Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...
GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines ...
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results